SUN’s FY22 prelims are in line with upgraded expectations, with revenues increasing by a notable 24%, taking the group back above pre-pandemic levels. Elective recovery remains patchy, but SUN continues to take market share by launching new products, opening new hospital accounts and new geographies. The outlook is reported to be positive and we make no change of our FY23 estimates, which look well supported. The group is now moving firmly towards sustained growth and margin improvement, and rem ....
29 Mar 2023
Moving from recovery to sustained growth & margin improvement
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Moving from recovery to sustained growth & margin improvement
Surgical Innovations Group plc (SUN:LON) | 0.5 0 0.0% | Mkt Cap: 4.66m
- Published:
29 Mar 2023 -
Author:
Chris Glasper -
Pages:
3
SUN’s FY22 prelims are in line with upgraded expectations, with revenues increasing by a notable 24%, taking the group back above pre-pandemic levels. Elective recovery remains patchy, but SUN continues to take market share by launching new products, opening new hospital accounts and new geographies. The outlook is reported to be positive and we make no change of our FY23 estimates, which look well supported. The group is now moving firmly towards sustained growth and margin improvement, and rem ....